Literature DB >> 23778033

Depression and insight in schizophrenia: comparisons of levels of deficits in social cognition and metacognition and internalized stigma across three profiles.

Paul H Lysaker1, Jen Vohs, Ilanit Hasson-Ohayon, Marina Kukla, Jena Wierwille, Giancarlo Dimaggio.   

Abstract

While research has paradoxically linked insight to greater emotional distress and depression in schizophrenia, little is known why and for whom insight can result in depression. One possibility is that internalized stigma and deficits in social cognition and metacognition are risk factors for insight to convert to depression. To explore this possibility we assessed insight, depression, internalized stigma, social cognition and metacognition for sixty five persons with schizophrenia spectrum disorders. We then performed a cluster analysis based on insight and depression scores. Three groups were produced by the cluster analysis: Good insight/Mild depression (n=22); Fair insight/Moderate depression (n=26) and Poor insight/Minimal depression (n=17). As predicted, ANOVA comparing groups revealed the three groups differed in social cognition, and the metacognitive mastery aspect of metacognition. Those with fair insight and moderate depression reported more internalized stigma than those with poor insight and minimal depression. Persons with good insight and mild depression had higher levels of social cognition and metacognitive mastery than the other two groups. These differences persisted when controlling for neurocognition and symptom severity. These findings point to the possibility that future research should examine whether bolstering metacognitive and social cognitive capacities may have a protective effect as persons are assisted to achieve insight. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2013        PMID: 23778033     DOI: 10.1016/j.schres.2013.05.025

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  26 in total

1.  The impact of cognitive insight, self-stigma, and medication compliance on the quality of life in patients with schizophrenia.

Authors:  Yin-Ju Lien; Hsin-An Chang; Yu-Chen Kao; Nian-Sheng Tzeng; Chien-Wen Lu; Ching-Hui Loh
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-07-29       Impact factor: 5.270

2.  Insight, self-stigma and psychosocial outcomes in Schizophrenia: a structural equation modelling approach.

Authors:  Y-J Lien; H-A Chang; Y-C Kao; N-S Tzeng; C-W Lu; C-H Loh
Journal:  Epidemiol Psychiatr Sci       Date:  2016-12-15       Impact factor: 6.892

3.  The Role of Insight in Moderating the Association Between Depressive Symptoms in People With Schizophrenia and Stigma Among Their Nearest Relatives: A Pilot Study.

Authors:  Dzmitry Krupchanka; Mikhail Katliar
Journal:  Schizophr Bull       Date:  2016-03-12       Impact factor: 9.306

4.  The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia.

Authors:  Silvana Galderisi; Alessandro Rossi; Paola Rocca; Alessandro Bertolino; Armida Mucci; Paola Bucci; Paola Rucci; Dino Gibertoni; Eugenio Aguglia; Mario Amore; Antonello Bellomo; Massimo Biondi; Roberto Brugnoli; Liliana Dell'Osso; Diana De Ronchi; Gabriella Di Emidio; Massimo Di Giannantonio; Andrea Fagiolini; Carlo Marchesi; Palmiero Monteleone; Lucio Oldani; Federica Pinna; Rita Roncone; Emilio Sacchetti; Paolo Santonastaso; Alberto Siracusano; Antonio Vita; Patrizia Zeppegno; Mario Maj
Journal:  World Psychiatry       Date:  2014-10       Impact factor: 49.548

5.  Metacognitive Deficits Predict Impaired Insight in Schizophrenia Across Symptom Profiles: A Latent Class Analysis.

Authors:  Paul H Lysaker; Emily Gagen; Abigail Wright; Jenifer L Vohs; Marina Kukla; Phillip T Yanos; Ilanit Hasson-Ohayon
Journal:  Schizophr Bull       Date:  2019-01-01       Impact factor: 9.306

6.  Overlap and Mutual Distinctions Between Clinical Recovery and Personal Recovery in People With Schizophrenia in a One-Year Study.

Authors:  Julien Dubreucq; Franck Gabayet; Ophélia Godin; Myrtille Andre; Bruno Aouizerate; Delphine Capdevielle; Isabelle Chereau; Julie Clauss-Kobayashi; Nathalie Coulon; Thierry D'Amato; Jean-Michel Dorey; Caroline Dubertret; Mégane Faraldo; Hakim Laouamri; Sylvain Leigner; Christophe Lancon; Marion Leboyer; Pierre-Michel Llorca; Jasmina Mallet; David Misdrahi; Christine Passerieux; Romain Rey; Baptiste Pignon; Benoit Schorr; Mathieu Urbach; Franck Schürhoff; Andrei Szoke; Guillaume Fond; Fabrice Berna
Journal:  Schizophr Bull       Date:  2022-03-01       Impact factor: 9.306

7.  Modeling determinants of medication attitudes and poor adherence in early nonaffective psychosis: implications for intervention.

Authors:  Richard J Drake; Merete Nordentoft; Gillian Haddock; Celso Arango; W Wolfgang Fleischhacker; Birte Glenthøj; Marion Leboyer; Stefan Leucht; Markus Leweke; Phillip McGuire; Andreas Meyer-Lindenberg; Dan Rujescu; Iris E Sommer; René S Kahn; Shon W Lewis
Journal:  Schizophr Bull       Date:  2015-03-05       Impact factor: 9.306

8.  The "Insight Paradox" in Schizophrenia: Magnitude, Moderators and Mediators of the Association Between Insight and Depression.

Authors:  Martino Belvederi Murri; Mario Amore; Pietro Calcagno; Matteo Respino; Valentina Marozzi; Mattia Masotti; Michele Bugliani; Marco Innamorati; Maurizio Pompili; Silvana Galderisi; Mario Maj
Journal:  Schizophr Bull       Date:  2016-04-11       Impact factor: 9.306

9.  Self-stigma in Serious Mental Illness: A Systematic Review of Frequency, Correlates, and Consequences.

Authors:  Julien Dubreucq; Julien Plasse; Nicolas Franck
Journal:  Schizophr Bull       Date:  2021-08-21       Impact factor: 9.306

10.  Relationship of insight with medication adherence and the impact on outcomes in patients with schizophrenia and bipolar disorder: results from a 1-year European outpatient observational study.

Authors:  Diego Novick; William Montgomery; Tamas Treuer; Jaume Aguado; Susanne Kraemer; Josep Maria Haro
Journal:  BMC Psychiatry       Date:  2015-08-05       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.